EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination

Ruhi Polara, Briony L Gliddon, Raja Ganesan, Lorena T Davies, John Toubia iD, Sakthi Lenin, Ghizal Siddiqui, Olivia Morris-Hanon, Melinda N Tea, Paul A B Moretti, Dung A Nguyen, Chung Hoow Kok und 8 weitere

Proceedings of the National Academy of Sciences · 31.03.2026 · 123 (13)

DOI: 10.1073/pnas.2602460123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.03.2026. Verfasst von Ruhi Polara und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia. Hauptthemen laut MEDLINE: Receptors, Immunologic, Glioblastoma, Ubiquitin-Protein Ligases, CD47 Antigen. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: DHAC | National Health and Medical Research Council (NHMRC), Channel 7 Children's Research Foundation (CRF), Tour de Cure (TDC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD47 is an innate immune checkpoint that inhibits phagocytosis by myeloid cells, contributing to immune evasion by cancer cells. CD47-blocking antibodies have limited efficacy in glioblastoma (GBM), and the cell-intrinsic role of CD47 is poorly understood. In this study, we show that CD47 is highly expressed at the invasive edge of GBM tumors, and its elevated expression correlates with poor patient survival. We demonstrate that CD47 loss impairs GBM cell proliferation, migration, and invasion, independent of immune activity, and leads to reduced tumor burden and prolonged survival in vivo. Our study identifies ROBO2 signaling as a key downstream effector of CD47 and demonstrates that loss of ROBO2 similarly reduces GBM cell proliferation and migration. Importantly, we have uncovered that CD47 stabilizes ROBO2 by sequestering the E3 ubiquitin ligase ITCH, thereby blocking ubiquitination and proteasomal degradation of ROBO2. These findings establish CD47 as a key regulator of GBM cell plasticity and highlight the therapeutic potential of targeting CD47 – ROBO2 signaling in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ImmunologicGlioblastomaUbiquitin-Protein LigasesCD47 AntigenBrain NeoplasmsRoundabout ProteinsHumansUbiquitinationAnimalsCell Line, TumorCell ProliferationSignal TransductionMiceCell MovementDisease ProgressionRepressor Proteins

Stichwörter der Autor:innen

CD47ITCHROBO2glioblastomaubiquitin

Substanzen

Roundabout ProteinsReceptors, ImmunologicUbiquitin-Protein LigasesCD47 AntigenITCH protein, humanROBO2 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.
  • Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases, University Clinic Cologne, Cologne 50931, Germany.
  • Data and Bioinformatics Innovation, Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA 5000, Australia.
  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC 3052, Australia.
  • School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia.
  • Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.

ORCID-Profile: John Toubia, Darren J Creek, Nirmal Robinson

Förderung

  • DHAC | National Health and Medical Research Council (NHMRC)
  • Channel 7 Children's Research Foundation (CRF)
  • Tour de Cure (TDC)
  • Neurosurgical Research Foundation (NRF)
  • Channel 7 Children’s Research Foundation

Zitieren

APA

Polara, R., Gliddon, B. L., Ganesan, R., Davies, L. T., Toubia, J., Lenin, S., Siddiqui, G., Morris-Hanon, O., Tea, M. N., Moretti, P. A. B., Nguyen, D. A., Kok, C. H., Shard, C., Staudacher, A. H., Brown, M. P., Creek, D. J., Gomez, G. A., Thomas, D., Pitson, S. M., & Robinson, N. (2026). CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination. Proceedings of the National Academy of Sciences, 123(13). https://doi.org/10.1073/pnas.2602460123

Vancouver

Polara R, Gliddon BL, Ganesan R, Davies LT, Toubia J, Lenin S, et al. CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination. Proceedings of the National Academy of Sciences. 2026;123(13). doi:10.1073/pnas.2602460123

BibTeX
@article{Polara2026,
  author = {Polara, Ruhi and Gliddon, Briony L and Ganesan, Raja and Davies, Lorena T and Toubia, John and Lenin, Sakthi and Siddiqui, Ghizal and Morris-Hanon, Olivia and Tea, Melinda N and Moretti, Paul A B and Nguyen, Dung A and Kok, Chung Hoow and Shard, Chloe and Staudacher, Alexander H and Brown, Michael P and Creek, Darren J and Gomez, Guillermo A and Thomas, Daniel and Pitson, Stuart M and Robinson, Nirmal},
  title = {CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {13},
  doi = {10.1073/pnas.2602460123}
}
Kostenlos starten →